![Carmen Betancourt](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Carmen Betancourt
General Counsel at CIDARA THERAPEUTICS, INC.
Carmen Betancourt active positions
Companies | Position | Start | End |
---|---|---|---|
CIDARA THERAPEUTICS, INC. | General Counsel | 01/01/2014 | - |
Golden Gate Bioventures LLC | Corporate Officer/Principal | 01/12/2013 | - |
Career history of Carmen Betancourt
Former positions of Carmen Betancourt
Companies | Position | Start | End |
---|---|---|---|
Sangart, Inc.
![]() Sangart, Inc. Pharmaceuticals: MajorHealth Technology Sangart, Inc. developed blood transfusion solutions. It is a global biopharmaceutical company dedicated to developing life-saving medicines specifically designed to enhance the perfusion and oxygenation of ischemic (oxygen deprived) tissues through targeted oxygen delivery. The company was founded in 1998 and was headquartered in San Diego, CA. | General Counsel | 01/01/2013 | 01/01/2014 |
Cerexa, Inc.
![]() Cerexa, Inc. Pharmaceuticals: MajorHealth Technology Cerexa, Inc. develops biopharmaceutical products. It is focuses on developing, acquiring and commercializing antibiotics to treat life-threatening, hospital-based infections. Cerexa's compound PPI-0903 is a cephalosporin used in treatment for complicated skin and skin-structure infections, as well as community-acquired and hospital-acquired pneumonias. The company was founded in 2005 and is headquartered in Alameda, CA. | General Counsel | 01/01/2008 | 01/01/2009 |
HUMANIGEN, INC. | General Counsel | 01/01/2006 | 01/01/2007 |
VaxGen, Inc.
![]() VaxGen, Inc. BiotechnologyHealth Technology VaxGen, Inc. is a biopharmaceutical company, owns a state-of-the-art biopharmaceutical manufacturing facility that can be used to make cell culture or microbial biologic products. The company has ended all product development activities and sold or otherwise terminated its drug development programs. It is seeking to maximize the value of its remaining tangible and intangible assets through a transaction or series of transactions, including the sale of the manufacturing facility. The company was founded on November 01, 1995 and is headquartered in South San Francisco, CA. | General Counsel | 01/01/2002 | 01/01/2006 |
TITAN PHARMACEUTICALS, INC. | General Counsel | 01/01/2001 | 01/01/2002 |
Coulter Pharmaceuticals, Inc.
![]() Coulter Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Founded in 1995, Coulter Pharmaceutical is engaged in the development of novel drugs and therapies for the treatment of people with cancer and autoimmune diseases. Currently under development is a family of therapeutics based upon two drug discovery platforms: therapeutic antibodies and targeted oncologics. | General Counsel | 01/01/1997 | 01/01/2000 |
Genentech, Inc.
![]() Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | General Counsel | 01/01/1992 | 01/01/1997 |
Training of Carmen Betancourt
Golden Gate University | Masters Business Admin |
University of California, Davis | Undergraduate Degree |
Statistics
International
United States | 12 |
Operational
General Counsel | 8 |
Corporate Officer/Principal | 1 |
Masters Business Admin | 1 |
Sectoral
Health Technology | 9 |
Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 3 |
---|---|
CIDARA THERAPEUTICS, INC. | Health Technology |
HUMANIGEN, INC. | Health Technology |
TITAN PHARMACEUTICALS, INC. | Health Technology |
Private companies | 6 |
---|---|
Golden Gate Bioventures LLC | |
Sangart, Inc.
![]() Sangart, Inc. Pharmaceuticals: MajorHealth Technology Sangart, Inc. developed blood transfusion solutions. It is a global biopharmaceutical company dedicated to developing life-saving medicines specifically designed to enhance the perfusion and oxygenation of ischemic (oxygen deprived) tissues through targeted oxygen delivery. The company was founded in 1998 and was headquartered in San Diego, CA. | Health Technology |
Cerexa, Inc.
![]() Cerexa, Inc. Pharmaceuticals: MajorHealth Technology Cerexa, Inc. develops biopharmaceutical products. It is focuses on developing, acquiring and commercializing antibiotics to treat life-threatening, hospital-based infections. Cerexa's compound PPI-0903 is a cephalosporin used in treatment for complicated skin and skin-structure infections, as well as community-acquired and hospital-acquired pneumonias. The company was founded in 2005 and is headquartered in Alameda, CA. | Health Technology |
VaxGen, Inc.
![]() VaxGen, Inc. BiotechnologyHealth Technology VaxGen, Inc. is a biopharmaceutical company, owns a state-of-the-art biopharmaceutical manufacturing facility that can be used to make cell culture or microbial biologic products. The company has ended all product development activities and sold or otherwise terminated its drug development programs. It is seeking to maximize the value of its remaining tangible and intangible assets through a transaction or series of transactions, including the sale of the manufacturing facility. The company was founded on November 01, 1995 and is headquartered in South San Francisco, CA. | Health Technology |
Coulter Pharmaceuticals, Inc.
![]() Coulter Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Founded in 1995, Coulter Pharmaceutical is engaged in the development of novel drugs and therapies for the treatment of people with cancer and autoimmune diseases. Currently under development is a family of therapeutics based upon two drug discovery platforms: therapeutic antibodies and targeted oncologics. | Health Technology |
Genentech, Inc.
![]() Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
- Stock Market
- Insiders
- Carmen Betancourt
- Experience